In the present study, we found that patients with high GP73 expression were more likely to obtain less tumor response than those with low or no GP73 expression, and further multivariate analysis found that GP73 expression served as one of the important predictors of pathologic tumor regression. Here, GOLM1 is linked to neoplasm.